Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

RHINITIS MEDICAMENTOSA

Known as: RHINITIS MEDICAMENTOUS 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Objective Rhinitis medicamentosa (RM) is a common condition resulting from overuse of topical nasal decongestants. Despite the… 
  • figure 1
  • table 2
2008
2008
Background The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate… 
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Review
2008
Review
2008
  • J. Doshi
  • European Archives of Oto-Rhino-Laryngology
  • 2008
  • Corpus ID: 1873947
Rhinitis medicamentosa (RM) is a drug induced non-allergic rhinitis associated with prolonged use of topical nasal decongestants… 
2007
2007
OBJECTIVE: Prolonged application of nasal vasoconstrictors causes rhinitis medicamentosa (RM). Nasal obstruction is induced by… 
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Review
2006
Review
2006
Rhinitis medicamentosa (RM) is a condition induced by overuse of nasal decongestants. The term RM, also called rebound or… 
  • table 1
  • table 2
  • table 3
Review
2005
Review
2005
  • Peter Graf
  • Treatments in respiratory medicine
  • 2005
  • Corpus ID: 25175067
Rhinitis medicamentosa (RM) is a drug-induced, nonallergic form of rhinitis that is associated with prolonged use of topical… 
2004
2004
To evaluate the nasal mucosal changes in rhinitis medicamentosa (RM), especially those related to goblet cells and subepithelial… 
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
Review
1999
Review
1999
  • P. Graf
  • Clinical therapeutics
  • 1999
  • Corpus ID: 23085385
Prolonged, repeated use of nasal decongestants for symptomatic relief of allergic rhinitis often results in rhinitis… 
Review
1997
Review
1997
  • P. Graf
  • Allergy
  • 1997
  • Corpus ID: 157921
With modern vasoconstrictors, such as oxy- and xylometazoline, the risk of developing rhinitis medicamentosa (RM) has been… 
Highly Cited
1997
Highly Cited
1997
With modern vasoconstrictors, such as oxy‐ and xylometazoline, the risk of developing rhinitis medicamentosa (RM) has been…